COLLEYVILLE, Texas--(BUSINESS WIRE)--Bone Solutions Inc. (BSI), an orthobiologics technology company located in Colleyville, Texas, announced today that it has received FDA 510(k) clearance for expanded indications for its Mg OSTEOINJECT. Mg OSTEOINJECT...
Orthofix’s patented Fitbone™ intramedullary nail system Orthofix’s patented Fitbone™ intramedullary nail system (pictured) together with LimaCorporate’s proprietary, patient specific, 3D-printed pelvic fixation device will meet the previously unmet need of patients...
NOBLESVILLE, Ind., July 12, 2022 (GLOBE NEWSWIRE) -- Nexxt Spine, LLC a leader in design and development of 3D printed, porous, titanium implants for the treatment of spinal disorders, announced the completion...
This marks the second medical facility to clinically use HOLO Portal, the world’s first artificial intelligence (AI)-driven, augmented reality (AR) guidance system for spine surgery. DEERFIELD, Ill., July 06, 2022 (GLOBE...
CHATTANOOGA, Tenn., June 29, 2022 /PRNewswire/ -- 3Spine, Inc., a medical device company developing total joint replacement for the lumbar spine, today announced completion of the first series of US surgeries in...
New center supports the Company's globalization efforts through increased surgeon training and education in Asia-Pacific region SAN DIEGO, June 29, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine...
BBS-Bioactive Bone Substitutes Plc Company Announcement 28 June 2022 17.00 (CEST) Trading on warrants 1-2022 (TO1) ja 2-2022 (TO2) issued by BBS-Bioactive Bone Substitutes Plc (“BBS” or the “Company”) begins on First...
Secures $40 Million in Financing to Support Continued Operations and Fund Growth June 15, 2022 02:26 PM Eastern Daylight Time POMPANO BEACH, Fla.--(BUSINESS WIRE)--Stimwave Technologies Incorporated and its subsidiary, Stimwave LLC (collectively,...
Lisa Jacobs promoted to serve as Vice President of SalesJim Fox promoted to East U.S. Vice President of SalesJay Shellhammer promoted to West U.S. Vice President of Sales PALM BEACH GARDENS,...
ATLANTA , June 9, 2022 /PRNewswire/ -- Lipogems is pleased to announce the unconditional approval by the U.S. Food and Drug Administration (FDA) to conduct an Investigational Device Exemption (IDE) study for treatment of...